Mary Elkins

5.8k total citations · 2 hit papers
9 papers, 4.1k citations indexed

About

Mary Elkins is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Mary Elkins has authored 9 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 6 papers in Virology and 2 papers in Epidemiology. Recurrent topics in Mary Elkins's work include HIV/AIDS drug development and treatment (7 papers), HIV Research and Treatment (6 papers) and HIV/AIDS Research and Interventions (4 papers). Mary Elkins is often cited by papers focused on HIV/AIDS drug development and treatment (7 papers), HIV Research and Treatment (6 papers) and HIV/AIDS Research and Interventions (4 papers). Mary Elkins collaborates with scholars based in United States, Cameroon and France. Mary Elkins's co-authors include Richard D. Gelber, Pamela Stratton, Edward H. O'Neill, Mary Jo O’Sullivan, Rhoda Sperling, William T. Shearer, Edward M. Connor, Jack Moye, Mary Culnane and Gwendolyn B. Scott and has published in prestigious journals such as New England Journal of Medicine, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Mary Elkins

9 papers receiving 3.9k citations

Hit Papers

Reduction of Maternal-Infant Transmission of Human Immuno... 1994 2026 2004 2015 1994 1995 500 1000 1.5k 2.0k 2.5k

Peers

Mary Elkins
Edward H. O'Neill United States
James Balsley United States
Eleanor Jiménez United States
P.N. Kiselev United States
Francis Mmiro United States
Ellen Cooper United States
Gwendolyn B. Scott United States
Manhattan Charurat United States
Edward H. O'Neill United States
Mary Elkins
Citations per year, relative to Mary Elkins Mary Elkins (= 1×) peers Edward H. O'Neill

Countries citing papers authored by Mary Elkins

Since Specialization
Citations

This map shows the geographic impact of Mary Elkins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Elkins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Elkins more than expected).

Fields of papers citing papers by Mary Elkins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Elkins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Elkins. The network helps show where Mary Elkins may publish in the future.

Co-authorship network of co-authors of Mary Elkins

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Elkins. A scholar is included among the top collaborators of Mary Elkins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Elkins. Mary Elkins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Lopez‐Ben, Robert, Ted R. Mikuls, Bruce A. Julian, et al.. (2004). Incidence of hip osteonecrosis among renal transplantation recipients: a prospective study. Clinical Radiology. 59(5). 431–438. 37 indexed citations
2.
Haas, David W., James P. Lavelle, Jeffrey P. Nadler, et al.. (2000). A Randomized Trial of Interferon alpha Therapy for HIV Type 1 Infection. AIDS Research and Human Retroviruses. 16(3). 183–190. 42 indexed citations
3.
Brady, Michael T., Nuala McGrath, Pim Brouwers, et al.. (1996). Randomized Study of the Tolerance and Efficacy of High-versus Low-Dose Zidovudine in Human Immunodeficiency Virus-Infected Children with Mild to Moderate Symptoms (AIDS Clinical Trials Group 128). The Journal of Infectious Diseases. 173(5). 1097–1106. 26 indexed citations
4.
McLaren, C., et al.. (1996). Inter-Company Collaboration for AIDS Drug Development: perspective on combination studies. Antiviral Research. 29(1). 119–122. 1 indexed citations
5.
Riddler, Sharon A., John Bartlett, Paul Savina, et al.. (1996). Safety and pharmacokinetics of 5-chloro-2',3'-dideoxy-3'-fluorouridine (935U83) following oral administration of escalating single doses in human immunodeficiency virus-infected adults. Antimicrobial Agents and Chemotherapy. 40(12). 2842–2847. 3 indexed citations
6.
Connor, Edward M., Rhoda Sperling, Richard D. Gelber, et al.. (1995). Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus 1 with Zidovudine Treatment. Obstetrical & Gynecological Survey. 50(4). 253–255. 1387 indexed citations breakdown →
7.
Elkins, Mary, et al.. (1995). Inter-Company Collaboration Combination Trials. Clinical Trial Subcommittee of the Inter-Company Collaboration for AIDS Drug Development.. PubMed. 10 Suppl 2. S92–6. 2 indexed citations
8.
Connor, Edward M., Rhoda Sperling, Richard D. Gelber, et al.. (1994). Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment. New England Journal of Medicine. 331(18). 1173–1180. 2509 indexed citations breakdown →
9.
Boucher, François D., John F. Modlin, S Weller, et al.. (1993). Phase I evaluation of zidovudine administered to infants exposed at birth to the human immunodeficiency virus. The Journal of Pediatrics. 122(1). 137–144. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026